82 related articles for article (PubMed ID: 29254256)
1. Dose age affect the efficacy of molecular targeted agents in the treatment of hepatocellular carcinoma: a systematic review and meta-analysis.
Du J; Mao Y; Liu M; Tie Y; Huang H; Zhao J; Xiang Z; Luo D
Oncotarget; 2017 Nov; 8(60):102413-102419. PubMed ID: 29254256
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of anti-VEGF agents in the treatment of elderly hepatocellular carcinoma: a systematic review.
Li X; Zhang D; Guan S; Ye W; Liu L; Lou L
Oncotarget; 2017 Nov; 8(54):93179-93185. PubMed ID: 29190987
[TBL] [Abstract][Full Text] [Related]
3. The role of targeted agents in the treatment of advanced gastric cancer: a meta-analysis of randomized controlled trials.
Wang CW; Fang XH
Eur Rev Med Pharmacol Sci; 2016 May; 20(9):1725-32. PubMed ID: 27212163
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of molecular targetted agents in the treatment of elderly patients with metastatic colorectal cancer: does the age matter?
Zhao C; Li S; Liu Q
J Chemother; 2016 Aug; 28(4):321-7. PubMed ID: 26239366
[TBL] [Abstract][Full Text] [Related]
5. A pooled analysis of molecularly targeted agents for treatment of metastatic oesophago-gastric cancer in elderly patients.
Lv H; Zhou QH; Zhong DS
Arch Med Sci; 2020; 16(2):253-259. PubMed ID: 32190134
[TBL] [Abstract][Full Text] [Related]
6. The role of angiogenesis inhibitors in the treatment of elderly patients with advanced non-small-cell lung cancer: A meta-analysis of eleven randomized controlled trials.
Tian RH; Wu X; Liu X; Yang JW; Ji HL; Yan YJ
J Cancer Res Ther; 2016; 12(2):571-5. PubMed ID: 27461612
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of molecular targeted agents in the treatment of elderly patients with metastatic colorectal cancer: Does the age matter?
Zhao CJ; Li S; Liu Q
J Cancer Res Ther; 2018; 14(Supplement):S79-S84. PubMed ID: 29578154
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of targeted agents in the treatment of elderly patients with advanced non-small-cell lung cancer: a systematic review and meta-analysis.
Chen J; Chen J; Wu X; Shi T; Kang M
Onco Targets Ther; 2016; 9():4797-803. PubMed ID: 27536143
[TBL] [Abstract][Full Text] [Related]
9. Does the age affect the efficacy of angiogenesis inhibitors in ovarian cancer? A meta-analysis of randomized controlled trials.
Miao H; Miao CX; Han J; Li N
Eur Rev Med Pharmacol Sci; 2017 Jul; 21(13):3047-3053. PubMed ID: 28742202
[TBL] [Abstract][Full Text] [Related]
10. Efficacy and toxicity of molecular targeted therapies in combination with docetaxel for metastatic castration-resistant prostate cancer: a meta-analysis of phase III randomized controlled trials.
Qi WX; Fu S; Zhang Q; Guo XM
J Chemother; 2015 Jun; 27(3):181-7. PubMed ID: 25492160
[TBL] [Abstract][Full Text] [Related]
11. Comparison of efficacy of immune checkpoint inhibitors (ICIs) between younger and older patients: A systematic review and meta-analysis.
Nishijima TF; Muss HB; Shachar SS; Moschos SJ
Cancer Treat Rev; 2016 Apr; 45():30-7. PubMed ID: 26946217
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of the Metabolic Marker Hexokinase-2 in Various Solid Tumors: A Meta-Analysis.
Liu Y; Wu K; Shi L; Xiang F; Tao K; Wang G
PLoS One; 2016; 11(11):e0166230. PubMed ID: 27824926
[TBL] [Abstract][Full Text] [Related]
13. Transarterial chemoembolization versus hepatic resection in hepatocellular carcinoma treatment: a meta-analysis.
Tian X; Dai Y; Wang DQ; Zhang L; Sui CG; Meng FD; Jiang SY; Liu YP; Jiang YH
Drug Des Devel Ther; 2015; 9():4431-40. PubMed ID: 26309396
[TBL] [Abstract][Full Text] [Related]
14. Does splenectomy significantly improve the prognosis of hepatocellular carcinoma patients with hypersplenism? A systematic review and meta-analysis.
Shi XB; Feng JK; Wang JH; Jiang XQ
Ann Transl Med; 2021 Apr; 9(8):641. PubMed ID: 33987339
[TBL] [Abstract][Full Text] [Related]
15. An updated meta-analysis of randomized controlled trials assessing the effect of sorafenib in advanced hepatocellular carcinoma.
Peng S; Zhao Y; Xu F; Jia C; Xu Y; Dai C
PLoS One; 2014; 9(12):e112530. PubMed ID: 25460347
[TBL] [Abstract][Full Text] [Related]
16. Association between sarcopenia and prognosis of hepatocellular carcinoma: A systematic review and meta-analysis.
Jiang C; Wang Y; Fu W; Zhang G; Feng X; Wang X; Wang F; Zhang L; Deng Y
Front Nutr; 2022; 9():978110. PubMed ID: 36590214
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibiting EGFR and VEGF pathways versus EGFR-TKIs alone in the treatment of advanced non-small-cell lung cancer: a meta-analysis of randomized controlled trials.
Zhang TT; Wang RM; Yang Z; Chen GB
Clin Transl Oncol; 2016 Jun; 18(6):576-81. PubMed ID: 26527033
[TBL] [Abstract][Full Text] [Related]
18. Maintenance Therapy Improves Survival Outcomes in Patients with Advanced Non-small Cell Lung Cancer: A Meta-analysis of 14 Studies.
Lu S; Yu Y; Chen Z; Ye X; Li Z; Niu X
Lung; 2015 Oct; 193(5):805-14. PubMed ID: 26119960
[TBL] [Abstract][Full Text] [Related]
19. Is There a Survival Benefit of First-Line Epidermal Growth Factor Receptor Tyrosine-Kinase Inhibitor Monotherapy Versus Chemotherapy in Patients with Advanced Non-Small-Cell Lung Cancer?: A Meta-Analysis.
Guetz GD; Landre T; Uzzan B; Chouahnia K; Nicolas P; Morere JF
Target Oncol; 2016 Feb; 11(1):41-7. PubMed ID: 26092590
[TBL] [Abstract][Full Text] [Related]
20. Multiple myeloma: myeloablative therapy with autologous stem cell support versus chemotherapy: a meta-analysis.
Faussner F; Dempke WC
Anticancer Res; 2012 May; 32(5):2103-9. PubMed ID: 22593496
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]